Dr. ADAM TABRIZ
Apr 26, 2024

--

The promise of GLP-1 receptor agonists (GLP-1 RAs) such as Tirzepatide and Semaglutide in the fight against diabetes takes us to exciting prospects— not only for this but also other related health conditions like osteoarthritis. A degenerative joint disease, osteoarthritis can result in significant pain, stiffness and limitation of function at the affected joints.

Recent research has suggested a protective effect on joint health by GLP-1 RAs: Tirzepatide and Semaglutide that might stop further development at osteoarthritis; thereby offering hope to those suffering from this condition.

Tirzepatide and Semaglutide have potential; they've been shown to be effective in bettering metabolic parameters and curtailing the process of inflammation. Scientists are delving into whether these medications might also possess neuroprotective capabilities, which could consequently mitigate dementia risk.

--

--

Dr. ADAM TABRIZ

In this vast tapestry of existence, I weave my thoughts and observations about all facets of life, offering a perspective that is uniquely my own.